Cargando…
First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor
Elevated cholesterol significantly increases the risk of developing atherosclerosis and coronary heart disease. The key to treating hypercholesterolemia is lowering plasma cholesterol levels. There have been no studies on the cholesterol-lowering potential of parthenolide (PTL), a naturally occurrin...
Autores principales: | Liu, Wenjing, Liang, Bing, Zeng, Jun, Meng, Jingsen, Shi, Lingyu, Yang, Shanbo, Chang, Jing, Wang, Chao, Hu, Xiaokun, Wang, Xufu, Han, Na, Lu, Chenghui, Li, Jiao, Wang, Congcong, Li, Huanting, Zhang, Renshuai, Xing, Dongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572688/ https://www.ncbi.nlm.nih.gov/pubmed/36234807 http://dx.doi.org/10.3390/molecules27196270 |
Ejemplares similares
-
The role of NPC1L1 in cancer
por: Zhang, Renshuai, et al.
Publicado: (2022) -
Inhibitory Effect of Isoliquiritigenin in Niemann-Pick C1-Like 1-Mediated Cholesterol Uptake
por: Zeng, Jun, et al.
Publicado: (2022) -
Research progress on antitumor activity of XRP44X and analogues as microtubule targeting agents
por: Wang, Chao, et al.
Publicado: (2023) -
Design, synthesis and biological evaluation of 9-aryl-5H-pyrido[4,3-b]indole derivatives as potential tubulin polymerization inhibitors
por: Shi, Lingyu, et al.
Publicado: (2022) -
Advances in antitumor research of CA-4 analogs carrying quinoline scaffold
por: Wang, Chao, et al.
Publicado: (2022)